Yumanity Therapeutics IncChange company Symbol lookupSelect an option...YMTX Yumanity Therapeutics IncBAC Bank of America CorpFIVN Five9 IncIPOF Social Capital Hedosophia Holdings Corp VINIO NIO IncNRT North European Oil Royalty TrustJNJ Johnson & JohnsonSTAG STAG Industrial IncTM Toyota Motor CorpHSIC Henry Schein IncGo
Yumanity Therapeutics Inc, formerly Proteostasis Therapeutics, Inc., is a clinical-stage biopharmaceutical company. The Company is engaged in treatment of neurodegenerative diseases through its scientific foundation and drug discovery platform. The platform is designed to enable the Company to screen for potential disease-modifying therapies by overcoming toxicity of misfolded proteins in neurogenerative diseases. The Company's product candidate, YTX-7739, is in Phase 1 clinical development for Parkinson's disease and YTX-9184, in IND-enabling studies for Dementia with Lewy Bodies. The Company’s pipeline consists of additional programs focused on multi- system atrophy, amyotrophic lateral sclerosis (ALS or Lou Gehrig's disease), frontotemporal lobar dementia (FTLD), and Alzheimer's disease.
|
|
|
|
| |
Upcoming Events
Past Earnings
GAAP vs. Non-GAAP Earnings
TD Ameritrade displays two types of stock earnings numbers, which are calculated differently and may report different values for the same period. GAAP earnings are the official numbers reported by a company, and non-GAAP earnings are adjusted to be more readable in earnings history and forecasts.
| Date | Event description | Earnings per share actual | Earnings estimate range | Previous year's actual |
|---|---|---|---|---|
| November 16, 2020 | Q3 Earnings Announcement | -- | -- | -- |
| November 16, 2020 | Q3 2020 Earnings Release | -$2.20 | -$0.21 to -$0.13 | -$5.00 |
| August 6, 2020 | Q2 Earnings Announcement | -- | -- | -- |
| August 6, 2020 | Q2 2020 Earnings Release | -$3.40 | -$0.23 to -$0.18 | -$7.80 |
| May 15, 2020 | Q1 Earnings Announcement | -- | -- | -- |
| May 15, 2020 | Q1 2020 Earnings Release | -$3.80 | -$0.31 to -$0.21 | -$5.60 |
| March 10, 2020 | Q4 Earnings Announcement | -- | -- | -- |
| March 10, 2020 | Q4 2019 Earnings Release | -$4.60 | -$0.33 to -$0.25 | -- |
Past Stock Splits
| Date | Event description | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| December 23, 2020 | 1:20 Stock Split | |||||||||
Earnings Calendar and Events Data provided by |Terms of Use| © 2021 Wall Street Horizon, Inc.
, , , Copyright © 2021. All rights reserved.
Reuters content is the intellectual property of Reuters. Any copying, republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters is not liable for any errors or delays in content, or for any actions taken in reliance on any content. Reuters, Reuters Logo and the Sphere Logo are trademarks and registered trademarks of the Reuters Group of companies around the world.
Data is provided for information purposes only and is not intended for trading purposes. Reuters shall not be liable for any errors or delay in the content, or for any action taken in reliance on any content. The RIC or Reuters Instrument Code set has been developed and maintained by Reuters and is the intellectual property of Reuters.